• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利妥昔单抗治疗混合型温抗体型与冷抗体型自身免疫性溶血性贫血取得良好疗效。

Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.

作者信息

Granel Brigitte, Rossi Pascal, Bernard Fanny, Dettori Isabelle, Costello Regis, Demoux Anne Laurence, Bagneres Denis, Lafforgue Pierre, Frances Yves

机构信息

Hopital Nord, Internal Medicine, Chemin des Bourrely, Marseille, 13915, France.

出版信息

BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0857. Epub 2009 Mar 6.

DOI:10.1136/bcr.09.2008.0857
PMID:21686597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3028234/
Abstract

Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative. The present study reports on a successful treatment with rituximab in a young woman suffering from a mixed warm and cold autoimmune haemolytic anaemia associated with a mixed connective tissue disease.

摘要

混合型温抗体与冷抗体自身免疫性贫血是一种罕见的溶血性贫血,通常与淋巴增殖性疾病和自身免疫性疾病相关。尽管类固醇疗法是一线治疗方法,但利妥昔单抗是一种很好的替代方案。本研究报告了一名患有混合型温抗体与冷抗体自身免疫性溶血性贫血并伴有混合性结缔组织病的年轻女性使用利妥昔单抗成功治疗的病例。

相似文献

1
Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.利妥昔单抗治疗混合型温抗体型与冷抗体型自身免疫性溶血性贫血取得良好疗效。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0857. Epub 2009 Mar 6.
2
Rituximab in the treatment of autoimmune haemolytic anaemia.利妥昔单抗治疗自身免疫性溶血性贫血
Br J Clin Pharmacol. 2015 May;79(5):709-19. doi: 10.1111/bcp.12498.
3
Mycophenolate Mofetil for the Treatment of Warm Autoimmune Haemolytic Anaemia Post-Rituximab Therapy: A Case Series.霉酚酸酯治疗利妥昔单抗治疗后温抗体型自身免疫性溶血性贫血:病例系列
Eur J Case Rep Intern Med. 2024 Aug 14;11(9):004780. doi: 10.12890/2024_004780. eCollection 2024.
4
A case of autoimmune haemolytic anaemia achieving complete response with rituximab.1例使用利妥昔单抗获得完全缓解的自身免疫性溶血性贫血病例。
J Pak Med Assoc. 2014 Jun;64(6):700-2.
5
[Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].[冷凝集素病——对糖皮质激素和利妥昔单抗无反应,三线治疗的最佳方案是什么?病例报告及文献综述]
Vnitr Lek. 2013 Sep;59(9):828-40.
6
[Autoimmune haemolytic anaemia: a review and report of four cases].[自身免疫性溶血性贫血:四例病例报告及文献综述]
Orv Hetil. 2015 Mar;156(11):449-56. doi: 10.1556/OH.2015.30105.
7
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.成人自身免疫性溶血性贫血的诊断与治疗:临床综述
Wien Klin Wochenschr. 2008;120(5-6):136-51. doi: 10.1007/s00508-008-0945-1.
8
A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative?自身免疫性溶血性贫血与新型冠状病毒肺炎的3例病例系列:血浆置换是一种选择吗?
SN Compr Clin Med. 2021;3(6):1420-1423. doi: 10.1007/s42399-021-00884-6. Epub 2021 Apr 14.
9
Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.混合型自身免疫性溶血性贫血:罕见病例及一例与脾 T 细胞血管免疫母细胞性非霍奇金淋巴瘤相关的病例
Hematology. 2007 Apr;12(2):159-62. doi: 10.1080/110245330601111466.
10
Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil.利妥昔单抗和霉酚酸酯成功治疗结节病继发的类固醇难治性自身免疫性溶血性贫血
Case Rep Hematol. 2016;2016:9495761. doi: 10.1155/2016/9495761. Epub 2016 Aug 2.

引用本文的文献

1
Rituximab in the treatment of autoimmune haemolytic anaemia.利妥昔单抗治疗自身免疫性溶血性贫血
Br J Clin Pharmacol. 2015 May;79(5):709-19. doi: 10.1111/bcp.12498.

本文引用的文献

1
Rituximab therapy for childhood Evans syndrome.利妥昔单抗治疗儿童埃文斯综合征。
Haematologica. 2007 Dec;92(12):1691-4. doi: 10.3324/haematol.11540.
2
Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
Rheumatology (Oxford). 2007 Oct;46(10):1628-9. doi: 10.1093/rheumatology/kem208. Epub 2007 Sep 1.
3
A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy.
Rheumatology (Oxford). 2007 Apr;46(4):718-9. doi: 10.1093/rheumatology/kem003. Epub 2007 Feb 8.
4
A patient with mixed connective tissue disease and mixed-type autoimmune hemolytic anemia.一名患有混合性结缔组织病和混合型自身免疫性溶血性贫血的患者。
Transfusion. 2005 Nov;45(11):1695-6. doi: 10.1111/j.1537-2995.2005.00633.x.
5
Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy.抗CD20单克隆抗体治疗与特发性膜性肾病相关的难治性自身免疫性溶血性贫血。
Rheumatology (Oxford). 2005 Mar;44(3):403-5. doi: 10.1093/rheumatology/keh463. Epub 2005 Jan 5.
6
Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients.利妥昔单抗治疗原发性慢性冷凝集素病:27例患者37个疗程的前瞻性研究
Blood. 2004 Apr 15;103(8):2925-8. doi: 10.1182/blood-2003-10-3597. Epub 2003 Dec 30.
7
Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.利妥昔单抗治疗与自身免疫性疾病:抗B细胞治疗的前景
Arthritis Rheum. 2003 Jun;48(6):1484-92. doi: 10.1002/art.10947.
8
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.利妥昔单抗治疗儿童难治性自身免疫性溶血性贫血
Blood. 2003 May 15;101(10):3857-61. doi: 10.1182/blood-2002-11-3547. Epub 2003 Jan 16.
9
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment.混合性温抗体型与冷抗体型自身免疫性溶血性贫血:利妥昔单抗治疗2个疗程后完全缓解
Blood. 2002 May 1;99(9):3478-9. doi: 10.1182/blood-2002-01-0018.
10
Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.抗RNP抗体患者混合性结缔组织病4种诊断标准集的比较研究。图卢兹医院自身免疫研究组。
J Rheumatol. 1996 Dec;23(12):2055-62.